David Lawrence
2007
In 2007, David Lawrence earned a total compensation of $1.2M as Chief Financial Officer at Acorda Therapeutics, a 98% increase compared to previous year.
Compensation breakdown
| Bonus | $55,366 |
|---|---|
| Option Awards | $946,753 |
| Salary | $236,600 |
| Other | $6,750 |
| Total | $1,245,469 |
Lawrence received $946.8K in option awards, accounting for 76% of the total pay in 2007.
Lawrence also received $55.4K in bonus, $236.6K in salary and $6.8K in other compensation.
Rankings
In 2007, David Lawrence's compensation ranked 3,473rd out of 8,700 executives tracked by ExecPay. In other words, Lawrence earned more than 60.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,473 out of 8,700 | 60th |
Division Manufacturing | 1,231 out of 3,314 | 63rd |
Major group Chemicals And Allied Products | 233 out of 746 | 69th |
Industry group Drugs | 126 out of 546 | 77th |
Industry Biological Products, Except Diagnostic Substances | 28 out of 118 | 76th |
Source: SEC filing on April 27, 2010.
Lawrence's colleagues
We found four more compensation records of executives who worked with David Lawrence at Acorda Therapeutics in 2007.